
    
      1. Visit 0 week

             -  Patients with subacute cough,area randomized to either ebastine/pseudoephedrine or
                placebo for 1 week.

             -  The cough severity and quality of life were measure with VAS score and
                cough-specific quality-of-life questionnaire(CQLQ)

        2. Visit 1 week check VAS score and CQLQ

        3. Visit 4 weeks check VAS score and CQLQ
    
  